Team

Group Members


The Legido-Quigley lab members are experts in a range of scientific fields such as biochemistry, pharmacology, medicine, clinical and analytical chemistry, statistics, bioinformatics and big data.

​Dr Tommi Suvitaival

Reseacher (Assistant Professor Level)

in Systems Medicine, Steno Diabetes Center


Tommi has been working as a researcher in Systems Medicine five years. Before that he did a PhD in Machine Learning (2015), his expertise in in bioinformatics, biostatistics, information visualization and statistical programming with R. He is a senior data analyst in the team and participates in many projects. His main project is INNODIA and he is Naba's co-supervisor. He oversees the IT, bioinformatics and data analyses pipelines in the team. See Tommi's publications in ORCID and visit his webpage.


Naba Al-Sari

PhD Candidate in Systems Medicine, Steno Diabetes Center


Naba started her PhD in 2018 (advisors CLQ and Flemming Pociot) and she is aiming to discover biomarkers in Type 1 Diabetes within Innodia. She started her work in systems medicine by studying adipose tissue collected in volunteers in an experimental setting, doing lipidomics, and in a theoretical one by integrating to transcriptomic repository data. She was recently chosen to represent Denmark in the Young Diabetologists Meeting in 2019 with her work in adipose tissue. Publications in ORCID

Annette Frost Bjerre

Senior Technican in Systems Medicine, Steno Diabetes Center


Annete joined the group in 2019 and she is a biomedical scientist with 30-year experience working in industry (Novo Nordisk). She is an expert in many molecular techniques and is currently developing methods for tissue sample preparation. She is also working in automation of sample preparation flows.

Dr Kourosh Hooshmand

Postdoc in Systems Medicine, Steno Diabetes Center


Kuorosh joined the group in 2021. He obtained his PhD in analytical chemistry from Aarhus University in Denmark in collaboration with Fiehn lab at UC Davis. He is an expert in targeted and untargeted metabolomics and lipidomics analyses (LC-MS/MS and GC-MS). His previous work has led to identifying various metabolic markers associated with thyroid cancers and plant host defense mechanisms. His current research focuses on utilizing lipidomics and metabolomics approaches to uncover the molecular mechanism underlying Alzheimer, others dementias & diabetes. Publicationc in ORCID


Dr Jin Xu

Postdoc in the Clinical Biomarkers Lab, King's College London


Jin finished her PhD in metabolomics in King's College London in 2019. An expert in experimental omics and data science she started a postdoc working in data analyses in a range of projects in collaboration with Petra Proitsi who is also her mentor. She has been the recipient of many prizes like the Young Lipid Scientist by the Society of Chemical Industry for her work in transplantation. She manages both the Q-TOF in the lab in KCL and the running of the lab in KCL. Publications in ORCID


I believe using high-precision mass spectrometry approaches and artificial intelligence can provide earlier diagnosis and treatment of diabetes and its complications.


- Naba Al-Sari

Dr Karolina Sulek

Reseacher (Assistant Professor Level)

in Systems Medicine, Steno Diabetes Center


Karolina did her PhD at the Technical University of Denmark and a post-doc at the University of Auckland. Upon return to Denmark she set up a metabolomics facility at the University of Copenhagen, helping researchers at the NNF Center for Basic Metabolic Research to understand T2D and obesity through metabolomics profiling. Her interest of the omics opened the path to proteomics at NNF Center for Protein Research in the group of Clinical Proteomics led by Matthias Mann. She will apply gained knowledge of the clinical multiomics within the MicrobLiver project and NNF Challenge Programme awarded to Torben Hansen and The Target project is a cohort to study the effects of the liver and gut health in obesity. Karolina's publications in Google Scholar

 


Jodie Lord

PhD Candidate in Neuroscience. MWCNI, King's College London


Jodie began her PhD in 2018 under the supervision of Petra Proitsi (together with Richard Dobson & CLQ). Her work aims to integrate metabolomic data with other 'omic' modalities in order to better predict Alzheimer's Disease risk. At present, she is working with genomic and metabolomic datasets and applying statistical techniques such as Mendelian Randomization and cross-trait Polygenic Risk Scoring to determine relationships - both correlative and causal - between metabolite levels and Alzheimer's Disease status. Publication in ORCID

I am passionate about describing biological systems through a molecular overview and I consider metabolomics as an excellent approach for answering a wide

range of clinical questions


- Andressa de Zawadzki

Dr Andressa de Zawadzki

Postdoc in Systems Medicine, Steno Diabetes Center


Andressa did a PhD in the field of metabolomics at the University of São Paulo and University of Copenhagen. She worked 2 years as a Postdoc in the Department of Food Science at the University of Copenhagen. In the Systems Medicine Group she is managing the wet lab and her research in liver metabolic disease is embedded in the EU Horizon2020 Galaxy project. Publications in ORCID

Ismo Mattila

Chemist in Systems Medicine, Steno Diabetes Center


Ismo is an analytical chemistry MSc that has contributed to many reports in the field with more than fifty publications to his name. He is an expert in GCxGC-QTOF and is responsable for the smooth running of projects with the platform and compound identification GC in several biological matrices. Publication in ORCID


I find exploring the complexity of the human metabolome fascinating and an important step towards personalized medicine"


- Asger Wretlind

Asger Wretlind

PhD Candidate in Systems Medicine, Steno Diabetes Center


Asger did a Masters in biochemistry and a project in industry (Novozymes). After that he joined our team in 2018 and worked in the targeted metabolomics and lipidomics platform. His PhD project looks into individual metabolic response to diabetes treatments and investigate biomarkers that can be used to direct personalized treatment. He oversees the pipeline for lipidomics analyses with CLQ via the QTOF. Publications in ORCID


 I see the underlying causes of a disease as a puzzle, and Multi-Omics as useful tools for identification of different parts of this puzzle. We need to take an integrative approach to put together all pieces and provide better health solutions


- Mina Ali

Dr Mina Ali

Postdoc in Systems Medicine, Steno Diabetes Center


Mina joined the group in 2020 as a bioinformatician in the Rhapsody IMI project. She did a PhD in cancer system's biology in Lund university of Sweden (2018). During her PhD studies she was involved in the analysis of genome-wide association studies, leading to identification of new risk alleles (biomarker) for the blood disorder Multiple Myeloma. She has a multidisciplinary background with a Bachelor's degree in engineering and two Masters degrees in Marketing and Bioinformatics. Publications in ORCID

Anchisa Poonprasartporn

PhD Candidate in Andrew Chan's Lab, IPS, King's College London


Anchisa started her PhD in 2017 in the Clinical Biomarkers Lab and moved to work in A.Chan's Lab when CLQ moved to Steno becoming her co-supervisor. She is working in deciphering the molecular mode of action of foods and herbal remedies in diabetes. In particular she is interested in the action of Tian Huan Fen. She is an expert in diabetes pharmacology and worked as a hospital pharmacist in Thailand. She uses state of the art spectroscopic techniques to understand energy metabolism.


Alumni and past lab members 


Postdocs (current company/institution): Dr Peter Heriksen (RegionH, Denmark), Dr Amera Ebshiana (Imperial College London, UK),  Dr Nadia Nielsen Aalling (University of Copenhagen, Denmark), Dr Min Kim (University of Copenhagen, Denmark), Dr Kajetan Trost (University of Copenhagen, Denmark), Dr Linda Ahonen (Biosynthia, Denmark), Dr Ashfaq Ali (National Bioinformatics Infrastructure, Sweden), Dr Stuart Snowden (Royal Holloway University, UK), Dr Petra Proitsi (King's College London, UK), Dr Arundhuti Sen (Glaxo SmithKline, UK).


PhD Students (current company/instituiton): Dr Jenn Nguyen (Waters Corp), Dr Amera Ebshiana (Imperial College London, UK), Dr Min Kim (Universy of Copenhagen, Denmark), Dr Pei Han (Pekin Union Medical College, China), Dr Anuri Shah (JOVE, India), Dr Wael Aljohani (University of Jeddah, Saudi), Dr Yao Yao Wang (WuXi Biologics, China), Dr Michael Jones (Waters Corp, US), Dr Erin Chambers (Waters Corp, US), MPhil Farnoush Azadi (Mibeg-Instituu Medizin, Germany), Dr Luke Whiley (Murdoch University, Australia), Dr James Heaton (Pfizer, UK), Dr Saowalak (Aor) Whungsinsujarit (TRIA, Thai Goverment, Thailand), Dr Shana Jacob (Sidra Medical and Research Center, Qatar), Dr Kittipong Sitthisinthu (TRIA, Thai Goverment, Thailand ), Dr Hsiao Ching Foo (Singapore Turf Club, Singapore).


Biomedical Staff: Nina Christiansen, Birgitte Neergards-Robert.


Academic Visitors: Dr Khalid Al-Qahtani, Dr Martina Palomino-Schatzelin, Dr Lin Zheng, Dr Ana Maria Casas, Dr Diego Garcia Gomez, Maria Tena, Prof Wenhui Gao, Prof Yong Huang, Dr Isabel Garcia-Perez, Antonio Grassano, Christina Abundis, Dr Raquel Hernandez.


Masters Students:

Raman Kaila (2020-2021), Faheem Ali (2020-2021), Ling Wang (2020), Chris Tsoi (2019-2020), Gulcan Yasar (2019-2020), Elmi Galado, Sabiha Hussain, Ho Chan, Tahmina Ahmad, Yangfei Cheng, Nan Liu,  Koo Wee Hiew, Kam Cheng, Vinesh Solanki, Mohammad Ally Hassan, Esther Santos-Gyasi, Lax Elanganathan, Faiza Sulaiman, Danting Wang, Mariam Mangal, Yaa Martey, Zohal Sakhi, Pelak Patel, Nuria Camina, Ali Ghalib Sheikh, Geetika Shah, Shreeya Patel, Maltina Shkodra, Wang Xiaoyu, Amish Patel, Kebedom Ghebrehiwet, Anna Allam, Dhiren Dayal, Setova Kpedekpo, Vinotha Tharmarajah, Maria del Carmen Velazquez Ortiz, Hajrah Yunus, Cheng Jiang, Nena Mistry, Zuo Chengchun, Archana Gnana Sekharan, Enoch Adjetey, Ting Yu, Oloma Nwodu, Tanika Rhule, Mufadal Jivanjee, Konstantina Papaspyridonos, Xiayan Li, Anna Mazgaj, Yingzi Hong, Echo, Sebastian Chinnu M, Sani Dennis Kerauni, Nicola Greenberg, Mahomed Suleman, Deena Patel, Krupali Joia, Rehan Ahmed, Nadira Mehjabin, Zeena Gosrani.    

Dr Nadia Nielsen Aalling

Postdoc  (BRIDGE Fellow 2019-2021) now in the University of Copenhagen CBMR


Nadia graduated with a PhD from University of Copenhagen in 2018. The aim of her research is to identify CNS-derived biomarkers for Type 2 Diabetes progression & remission. She uses single-cell sequencing & metabolomics to assess molecular changes.  Publications in ORCID


Dr Amera Ebshiana

MSc, PhD and Postdoc in the Clinical Biomarkers Lab, King's College London now in Imperial College London


Amera studied and worked 8 years at King's College London in the field of Alzheimer's Dementia. She is also an expert in working with brain tissue and published key papers in the field. Amera is also a GC-MS  and LC-MS expert. Publications in ORCID.